Steven Valiquette
Stock Analyst at Mizuho Securities
(1.44)
# 3,501
Out of 4,520 analysts
706
Total ratings
51.9%
Success rate
-0.1%
Average return
Main Sectors:
Stocks Rated by Steven Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintained: Buy | $295 → $270 | $197.37 | +36.80% | 10 | Jun 3, 2026 | |
| DOCS Doximity | Maintained: Hold | $34 → $26 | $22.21 | +17.06% | 8 | May 14, 2026 | |
| XRAY DENTSPLY SIRONA | Maintained: Hold | $16 → $14 | $13.85 | +1.08% | 31 | May 6, 2026 | |
| HSIC Henry Schein | Maintained: Hold | $88 → $82 | $88.26 | -7.09% | 23 | May 6, 2026 | |
| ALGN Align Technology | Maintained: Buy | $215 → $220 | $178.41 | +23.31% | 34 | Apr 30, 2026 | |
| PHR Phreesia | Maintained: Buy | $22 → $19 | $10.89 | +74.47% | 4 | Mar 24, 2026 | |
| LFMD LifeMD | Upgraded: Buy | $6 → $8 | $4.50 | +77.78% | 8 | Mar 16, 2026 | |
| GDRX GoodRx Holdings | Maintained: Hold | $4 → $3 | $3.12 | -3.85% | 7 | Feb 27, 2026 | |
| TDOC Teladoc Health | Maintained: Hold | $10 → $6 | $9.47 | -36.64% | 23 | Feb 26, 2026 | |
| MDLN Medline | Maintained: Buy | $48 → $53 | $41.11 | +28.92% | 2 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $6 | $5.22 | +14.94% | 5 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $235 | $228.72 | +2.75% | 33 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $885 | $841.31 | +5.19% | 45 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 → $27 | $26.99 | +0.04% | 9 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $42 | $23.17 | +81.27% | 6 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $85 → $100 | $81.70 | +22.40% | 5 | Jan 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $340 → $380 | $307.99 | +23.38% | 36 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $126 | $98.69 | n/a | 7 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $585 | $386.48 | n/a | 12 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $10 | $4.82 | n/a | 16 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $86 | $106.50 | n/a | 27 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $5 | $40.47 | n/a | 10 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $15.28 | n/a | 13 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $13 | $20.16 | n/a | 16 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $24 | $21.29 | n/a | 6 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $575 | $372.85 | n/a | 22 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $20 | $41.97 | n/a | 18 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $55 | $95.04 | n/a | 20 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $31 | $49.87 | n/a | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $355 | $283.82 | n/a | 19 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $82 → $92 | $241.49 | n/a | 22 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $105 | $199.20 | n/a | 20 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $63 → $61 | $112.49 | n/a | 4 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $300 | $385.74 | n/a | 16 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $375 | $224.82 | n/a | 20 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $142 | $153.54 | n/a | 18 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $32 | $22.33 | n/a | 16 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $565 | $423.38 | n/a | 21 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 → $86 | $63.89 | n/a | 11 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $1 → $2 | $30.76 | n/a | 8 | Jun 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $35 → $34 | $41.67 | n/a | 3 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $30 | $0.35 | n/a | 6 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $16 | $1.49 | n/a | 10 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $5 | $0.7197 | n/a | 6 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $26 → $19 | $11.87 | n/a | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $15 | $9.90 | n/a | 3 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $6 → $10 | $3.38 | n/a | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 → $33 | $3.78 | n/a | 15 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $105 → $135 | $234.01 | n/a | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $11.49 | n/a | 1 | Jun 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $19 → $14 | $4.90 | n/a | 3 | May 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $209.41 | n/a | 2 | Mar 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $49 | $229.16 | n/a | 1 | Sep 17, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $50 | $170.00 | n/a | 1 | Sep 17, 2013 |
Veeva Systems
Jun 3, 2026
Maintained: Buy
Price Target: $295 → $270
Current: $197.37
Upside: +36.80%
Doximity
May 14, 2026
Maintained: Hold
Price Target: $34 → $26
Current: $22.21
Upside: +17.06%
DENTSPLY SIRONA
May 6, 2026
Maintained: Hold
Price Target: $16 → $14
Current: $13.85
Upside: +1.08%
Henry Schein
May 6, 2026
Maintained: Hold
Price Target: $88 → $82
Current: $88.26
Upside: -7.09%
Align Technology
Apr 30, 2026
Maintained: Buy
Price Target: $215 → $220
Current: $178.41
Upside: +23.31%
Phreesia
Mar 24, 2026
Maintained: Buy
Price Target: $22 → $19
Current: $10.89
Upside: +74.47%
LifeMD
Mar 16, 2026
Upgraded: Buy
Price Target: $6 → $8
Current: $4.50
Upside: +77.78%
GoodRx Holdings
Feb 27, 2026
Maintained: Hold
Price Target: $4 → $3
Current: $3.12
Upside: -3.85%
Teladoc Health
Feb 26, 2026
Maintained: Hold
Price Target: $10 → $6
Current: $9.47
Upside: -36.64%
Medline
Feb 26, 2026
Maintained: Buy
Price Target: $48 → $53
Current: $41.11
Upside: +28.92%
Feb 20, 2026
Maintained: Buy
Price Target: $4 → $6
Current: $5.22
Upside: +14.94%
Feb 10, 2026
Maintained: Buy
Price Target: $235
Current: $228.72
Upside: +2.75%
Feb 10, 2026
Maintained: Hold
Price Target: $885
Current: $841.31
Upside: +5.19%
Feb 10, 2026
Maintained: Hold
Price Target: $24 → $27
Current: $26.99
Upside: +0.04%
Feb 4, 2026
Maintained: Buy
Price Target: $50 → $42
Current: $23.17
Upside: +81.27%
Jan 20, 2026
Upgraded: Buy
Price Target: $85 → $100
Current: $81.70
Upside: +22.40%
Nov 6, 2025
Maintained: Buy
Price Target: $340 → $380
Current: $307.99
Upside: +23.38%
Jul 2, 2025
Reiterated: Buy
Price Target: $126
Current: $98.69
Upside: n/a
Aug 23, 2023
Rated: Buy
Price Target: $585
Current: $386.48
Upside: n/a
Aug 21, 2023
Rated: Buy
Price Target: $12 → $10
Current: $4.82
Upside: n/a
Aug 17, 2023
Rated: Buy
Price Target: $86
Current: $106.50
Upside: n/a
Aug 14, 2023
Rated: Sell
Price Target: $5
Current: $40.47
Upside: n/a
Aug 10, 2023
Maintained: Buy
Price Target: $7
Current: $15.28
Upside: n/a
Aug 10, 2023
Rated: Hold
Price Target: $13
Current: $20.16
Upside: n/a
Aug 10, 2023
Rated: Buy
Price Target: $25 → $24
Current: $21.29
Upside: n/a
Aug 8, 2023
Rated: Buy
Price Target: $575
Current: $372.85
Upside: n/a
Aug 8, 2023
Rated: Hold
Price Target: $20
Current: $41.97
Upside: n/a
Aug 7, 2023
Rated: Buy
Price Target: $55
Current: $95.04
Upside: n/a
Aug 4, 2023
Rated: Hold
Price Target: $31
Current: $49.87
Upside: n/a
Aug 3, 2023
Reiterated: Buy
Price Target: $355
Current: $283.82
Upside: n/a
Aug 1, 2023
Reiterated: Buy
Price Target: $82 → $92
Current: $241.49
Upside: n/a
Aug 1, 2023
Rated: Buy
Price Target: $105
Current: $199.20
Upside: n/a
Jul 28, 2023
Rated: Hold
Price Target: $63 → $61
Current: $112.49
Upside: n/a
Jul 27, 2023
Maintained: Hold
Price Target: $300
Current: $385.74
Upside: n/a
Jul 27, 2023
Rated: Buy
Price Target: $375
Current: $224.82
Upside: n/a
Jul 27, 2023
Rated: Hold
Price Target: $142
Current: $153.54
Upside: n/a
Jul 25, 2023
Maintained: Buy
Price Target: $33 → $32
Current: $22.33
Upside: n/a
Jul 14, 2023
Maintained: Buy
Price Target: $565
Current: $423.38
Upside: n/a
Jul 12, 2023
Maintained: Buy
Price Target: $100 → $86
Current: $63.89
Upside: n/a
Jun 29, 2023
Rated: Hold
Price Target: $1 → $2
Current: $30.76
Upside: n/a
May 3, 2023
Maintained: Sell
Price Target: $35 → $34
Current: $41.67
Upside: n/a
Mar 2, 2022
Maintained: Hold
Price Target: $45 → $30
Current: $0.35
Upside: n/a
Mar 1, 2022
Maintained: Hold
Price Target: $22 → $16
Current: $1.49
Upside: n/a
Feb 8, 2022
Maintained: Hold
Price Target: $9 → $5
Current: $0.7197
Upside: n/a
Aug 12, 2021
Upgraded: Buy
Price Target: $26 → $19
Current: $11.87
Upside: n/a
Aug 12, 2021
Maintained: Buy
Price Target: $19 → $15
Current: $9.90
Upside: n/a
Aug 3, 2021
Maintained: Sell
Price Target: $6 → $10
Current: $3.38
Upside: n/a
Feb 25, 2021
Maintained: Hold
Price Target: $23 → $33
Current: $3.78
Upside: n/a
Jan 15, 2021
Maintained: Buy
Price Target: $105 → $135
Current: $234.01
Upside: n/a
Jun 30, 2017
Downgraded: Sell
Price Target: n/a
Current: $11.49
Upside: n/a
May 15, 2017
Initiated Coverage: Hold
Price Target: $19 → $14
Current: $4.90
Upside: n/a
Mar 16, 2017
Upgraded: Hold
Price Target: n/a
Current: $209.41
Upside: n/a
Sep 17, 2013
Initiated Coverage: Hold
Price Target: $49
Current: $229.16
Upside: n/a
Sep 17, 2013
Initiated Coverage: Buy
Price Target: $50
Current: $170.00
Upside: n/a